v3.25.2
Property, plant and equipment (Tables)
12 Months Ended
Mar. 31, 2025
Text Block1 [Abstract]  
Summary of changes in property, plant and equipment
The changes in property, plant and equipment for the fiscal years ended March 31, 2024 and 2025 are as follows:
 
   
Yen in millions
 
   
Land
         
Buildings
         
Machinery and
equipment
         
Construction
in progress
         
Total
 
Balance as of April 1, 2023:                  
Cost
     79,291          921,156          2,202,010          201,299          3,403,756  
Accumulated depreciation and impairment losses
     (37        (541,853        (1,515,838        (1,164        (2,058,892
  
 
 
      
 
 
      
 
 
      
 
 
      
 
 
 
Carrying amount
     79,254          379,303          686,172          200,135          1,344,864  
  
 
 
      
 
 
      
 
 
      
 
 
      
 
 
 
Changes in carrying amount:                       
Additions
     6,068          14,886          100,199          374,735          495,888  
Acquisitions through business combinations
     -          912          472          12          1,396  
Reclassifications
     616          76,731          314,967          (394,995        (2,681
Disposals or classified as held for sale
*1
     (2,077        (2,361        (3,416        (1,414        (9,268
Depreciation
*2
     -          (39,781        (281,807        -          (321,588
Impairment losses
     -          (76        (258        (11        (345
Translation adjustment
     2,085          15,913          7,366          5,729          31,093  
Other
     -          (1,744        (15,032        57          (16,719
  
 
 
      
 
 
      
 
 
      
 
 
      
 
 
 
Total changes
     6,692          64,480          122,491          (15,887        177,776  
  
 
 
      
 
 
      
 
 
      
 
 
      
 
 
 
Balance as of March 31, 2024:                       
Cost
     85,983          1,033,758          2,551,174          185,287          3,856,202  
Accumulated depreciation and impairment losses
     (37        (589,975        (1,742,511        (1,039        (2,333,562
  
 
 
      
 
 
      
 
 
      
 
 
      
 
 
 
Carrying amount
     85,946          443,783          808,663          184,248          1,522,640  
  
 
 
      
 
 
      
 
 
      
 
 
      
 
 
 
Changes in carrying amount:                       
Additions
  
 
2,815
 
    
 
19,701
 
    
 
76,224
 
    
 
248,163
 
    
 
346,903
 
Acquisitions through business combinations
  
 
258
 
    
 
12,511
 
    
 
3,964
 
    
 
1,221
 
    
 
17,954
 
Reclassifications
  
 
371
 
    
 
56,556
 
    
 
213,401
 
    
 
(273,978
    
 
(3,650
Disposals or classified as held for sale
*1
  
 
(657
    
 
(1,957
    
 
(5,762
    
 
(984
    
 
(9,360
Depreciation
*2
  
 
-
 
    
 
(45,722
    
 
(301,344
    
 
-
 
    
 
(347,066
Impairment losses
  
 
-
 
    
 
(1,154
    
 
(645
    
 
(203
    
 
(2,002
Translation adjustment
  
 
(162
    
 
(2,051
    
 
901
 
    
 
497
 
    
 
(815
Other
  
 
54
 
    
 
(212
    
 
(10,904
    
 
118
 
    
 
(10,944
  
 
 
      
 
 
      
 
 
      
 
 
      
 
 
 
Total changes
  
 
2,679
 
    
 
37,672
 
    
 
(24,165
    
 
(25,166
    
 
(8,980
  
 
 
      
 
 
      
 
 
      
 
 
      
 
 
 
Balance as of March 31, 2025:                       
Cost
  
 
88,662
 
    
 
1,093,460
 
    
 
2,719,283
 
    
 
159,963
 
    
 
4,061,368
 
Accumulated depreciation and impairment losses
  
 
(37
    
 
(612,005
    
 
(1,934,785
    
 
(881
    
 
(2,547,708
  
 
 
      
 
 
      
 
 
      
 
 
      
 
 
 
Carrying amount
  
 
88,625
 
    
 
481,455
 
    
 
784,498
 
    
 
159,082
 
    
 
1,513,660
 
  
 
 
      
 
 
      
 
 
      
 
 
      
 
 
 
 
*1
An asset or disposal group for which the cash flows are expected to arise principally from sale rather than continuing use is classified to current asset as an asset held for sale.
 
*2
Depreciation expenses are allocated to the cost of inventory and are recognized in cost of sales as inventory is sold, or are directly recognized in selling, general and administrative expenses and research and development expenditures in the consolidated statements of income, depending on the use of the asset.